|
TRML Tourmaline Bio Inc 1827506 |
| Balance Sheet |
|
Current Assets
|
293,785,000 |
|
Assets
|
328,447,000 |
|
Current Liabilities
|
7,284,000 |
|
Liabilities
|
7,379,000 |
|
Equity
|
321,068,000 |
|
Shares Out
|
25,641,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-56,374,000 |
|
Investing Cash Flow
|
-210,695,000 |
| Market Analysis |
Market Cap
|
721,163,250 |
|
Price
|
18.00 |
|
BVPS
|
12.52 |
|
PB
|
1.42 |
|
EPS
|
-2.54 |
|
PS
|
1.15 |
|
FCF
|
-267,069,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TRML documents filed with the SEC.
TRML Filings
Clear
